{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T23:03:05Z","timestamp":1775775785904,"version":"3.50.1"},"reference-count":141,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:00:00Z","timestamp":1759017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R50CA275877"],"award-info":[{"award-number":["R50CA275877"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Biliary tract cancers include cholangiocarcinoma, gallbladder cancer, and ampullary cancer. Although overall rare, the incidence is increasing globally, particularly the subset of intrahepatic cholangiocarcinoma. Surgery is currently considered to be the only curative treatment approach; however, survival outcomes after surgery remain poor. Moreover, many patients already have advanced-stage, unresectable disease at the time of diagnosis. Herein, we will review the role of adjuvant radiotherapy to improve local control after surgery, the role of neoadjuvant radiotherapy to increase the proportion of patients able to undergo surgery, and the use of definitive\/palliative radiotherapy to provide local control\/symptom relief for patients who have inoperable disease. Most studies observed a survival benefit associated with radiotherapy, with the strongest evidence for those with high-risk disease features (e.g., positive surgical margins, lymph node involvement). However, due to the low incidence of biliary tract cancers, most existing studies are retrospective; there is very limited randomized data and prospective studies tend to have small sample sizes, underscoring the need for more high-quality research on radiotherapy for biliary tract cancers. As some studies show evidence of a dose-dependent response, further investigation into the delivery of dose-escalated radiotherapy with modern techniques such as proton therapy is warranted.<\/jats:p>","DOI":"10.3390\/curroncol32100545","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:01:39Z","timestamp":1759154499000},"page":"545","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Role of Radiation Therapy for Biliary Tract Cancers"],"prefix":"10.3390","volume":"32","author":[{"given":"Molly A.","family":"Chakraborty","sequence":"first","affiliation":[{"name":"Rutgers New Jersey Medical School, Newark, NJ 07103, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0982-6277","authenticated-orcid":false,"given":"Ritesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Rutgers Cancer Institute, New Brunswick, NJ 08901, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett L.","family":"Ecker","sequence":"additional","affiliation":[{"name":"Department of Surgery, Rutgers Cancer Institute, New Brunswick, NJ 08901, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haejin","family":"In","sequence":"additional","affiliation":[{"name":"Department of Surgery, Rutgers Cancer Institute, New Brunswick, NJ 08901, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell C.","family":"Langan","sequence":"additional","affiliation":[{"name":"Department of Surgery, Rutgers Cancer Institute, New Brunswick, NJ 08901, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Eskander","sequence":"additional","affiliation":[{"name":"Department of Surgery, Rutgers Cancer Institute, New Brunswick, NJ 08901, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salma K.","family":"Jabbour","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Rutgers Cancer Institute, New Brunswick, NJ 08901, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary Tract Cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Koshiol, J., Yu, B., Kabadi, S.M., Baria, K., and Shroff, R.T. (2022). Epidemiologic Patterns of Biliary Tract Cancer in the United States: 2001\u20132015. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-10286-z"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","article-title":"Risk Factors for Intrahepatic and Extrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis","volume":"72","author":"Clements","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Labib, P.L., Goodchild, G., and Pereira, S.P. (2019). Molecular Pathogenesis of Cholangiocarcinoma. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-5391-0"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/sj.bjc.6604047","article-title":"Gallstones and the Risk of Biliary Tract Cancer: A Population-Based Study in China","volume":"97","author":"Hsing","year":"2007","journal-title":"Br. J. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Moreno, P., Riquelme, I., Garc\u00eda, P., Brebi, P., and Roa, J.C. (2022). Environmental and Lifestyle Risk Factors in the Carcinogenesis of Gallbladder Cancer. J. Pers. Med., 12.","DOI":"10.3390\/jpm12020234"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e18754","DOI":"10.1097\/MD.0000000000018754","article-title":"Risk Factors for Gallstone Disease in Shanghai: An Observational Study","volume":"99","author":"Gu","year":"2020","journal-title":"Medicine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ueg2.12281","article-title":"Risk Factors for the Occurrence of Ampullary Tumors: A Case-Control Study","volume":"10","author":"Zaccari","year":"2022","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"9541","DOI":"10.3748\/wjg.v20.i28.9541","article-title":"Association of Metabolic Syndromes and Risk Factors with Ampullary Tumors Development: A Case-Control Study in China","volume":"20","author":"He","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_10","unstructured":"American College of Surgeons (2025). AJCC Cancer Staging System, American College of Surgeons."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/curroncol30010030","article-title":"Pathology of Cholangiocarcinomas","volume":"30","author":"Guedj","year":"2023","journal-title":"Curr. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.17998\/jlc.2023.12.11","article-title":"Intrahepatic Cholangiocarcinoma: Histological Diversity and the Role of the Pathologist","volume":"24","author":"Komuta","year":"2024","journal-title":"J. Liver Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.humpath.2022.06.013","article-title":"Gallbladder Carcinomas: Review and Updates on Morphology, Immunohistochemistry, and Staging","volume":"132","author":"Lee","year":"2023","journal-title":"Hum. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6996","DOI":"10.3390\/curroncol30070507","article-title":"Ampullary Cancer: Histological Subtypes, Markers, and Clinical Behaviour\u2014State of the Art and Perspectives","volume":"30","author":"Nappo","year":"2023","journal-title":"Curr. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.21037\/cco.2019.08.09","article-title":"Cholangiocarcinoma: A Site-Specific Update on the Current State of Surgical Management and Multi-Modality Therapy","volume":"9","author":"Turgeon","year":"2020","journal-title":"Chin. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.surg.2021.09.038","article-title":"Resectable Intrahepatic and Hilar Cholangiocarcinoma: Is Margin Status Associated with Survival?","volume":"171","author":"Littau","year":"2022","journal-title":"Surgery"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA","volume":"71","author":"Sung","year":"2021","journal-title":"Cancer J. Clin."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","article-title":"Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise","volume":"21","author":"Saha","year":"2016","journal-title":"Oncologist"},{"key":"ref_19","unstructured":"National Comprehensive Cancer Network (2025, March 05). NCCN Guidelines Version 6.2024 Biliary Tract Cancers. Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/btc.pdf."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.radonc.2018.05.011","article-title":"Outcomes of Adjuvant Treatments for Resectable Intrahepatic Cholangiocarcinoma: Chemotherapy Alone, Sequential Chemoradiotherapy, or Concurrent Chemoradiotherapy","volume":"128","author":"Lin","year":"2018","journal-title":"Radiother. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/cncr.30968","article-title":"The Role of Surgery and Adjuvant Therapy in Lymph Node\u2013Positive Cancers of the Gallbladder and Intrahepatic Bile Ducts","volume":"124","author":"Zhang","year":"2018","journal-title":"Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s00268-019-04966-4","article-title":"Trends in the Incidence, Treatment and Outcomes of Patients with Intrahepatic Cholangiocarcinoma in the USA: Facility Type Is Associated with Margin Status, Use of Lymphadenectomy and Overall Survival","volume":"43","author":"Wu","year":"2019","journal-title":"World J. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s00066-017-1128-7","article-title":"Improved Oncologic Outcome with Chemoradiotherapy Followed by Surgery in Unresectable Intrahepatic Cholangiocarcinoma","volume":"193","author":"Cho","year":"2017","journal-title":"Strahlenther. Onkol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1007\/s00268-018-4558-1","article-title":"Chemoradiotherapy for Initially Unresectable Locally Advanced Cholangiocarcinoma","volume":"42","author":"Sumiyoshi","year":"2018","journal-title":"World J. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijrobp.2008.03.018","article-title":"Radiation Therapy Is Associated with Improved Survival in the Adjuvant and Definitive Treatment of Intrahepatic Cholangiocarcinoma","volume":"72","author":"Shinohara","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3892\/mco.2016.1072","article-title":"Clinical Analysis of Cholangiocarcinoma Patients Receiving Adjuvant Radiotherapy","volume":"5","author":"Nantajit","year":"2016","journal-title":"Mol. Clin. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e16673","DOI":"10.1097\/MD.0000000000016673","article-title":"Outcome of Postoperative Radiation Therapy for Cholangiocarcinoma and Analysis of Dose-Volume Histogram of Remnant Liver","volume":"98","author":"Mukai","year":"2019","journal-title":"Medicine"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jss.2019.04.023","article-title":"Downstaging Locally Advanced Cholangiocarcinoma Pre-Liver Transplantation: A Prospective Pilot Study","volume":"242","author":"Wong","year":"2019","journal-title":"J. Surg. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s12029-021-00696-w","article-title":"Analysis of Post-Operative Adjuvant Chemotherapy Versus Adjuvant Chemoradiation Therapy Outcomes in Non-Metastatic Cholangiocarcinoma: An NCDB Review","volume":"53","author":"Rodriguez","year":"2022","journal-title":"J. Gastrointest. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2015.64.2710","article-title":"Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients with Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma","volume":"34","author":"Hong","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s13014-020-01703-3","article-title":"Hypofractionated Proton Beam Radiotherapy in Patients with Unresectable Liver Tumors: Multi-Institutional Prospective Results from the Proton Collaborative Group","volume":"15","author":"Parzen","year":"2020","journal-title":"Radiat. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1245\/s10434-019-08142-9","article-title":"Hypofractionated Radiation Therapy for Unresectable\/Locally Recurrent Intrahepatic Cholangiocarcinoma","volume":"27","author":"Smart","year":"2020","journal-title":"Ann. Surg. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Zhu, M., Jin, M., Zhao, X., Shen, S., Chen, Y., Xiao, H., Wei, G., He, Q., Li, B., and Peng, Z. (2024). Anti-PD-1 Antibody in Combination with Radiotherapy as First-Line Therapy for Unresectable Intrahepatic Cholangiocarcinoma. BMC Med., 22.","DOI":"10.1186\/s12916-024-03381-4"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1200\/JCO.2015.61.3778","article-title":"Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients with Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis","volume":"34","author":"Tao","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.2007.14.3529","article-title":"Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma","volume":"26","author":"Tse","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.radonc.2009.11.004","article-title":"Stereotactic Body Radiotherapy for Unresectable Cholangiocarcinoma","volume":"94","author":"Kopek","year":"2010","journal-title":"Radiother. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00066-018-1367-2","article-title":"Efficacy of Stereotactic Body Radiotherapy for Unresectable or Recurrent Cholangiocarcinoma: A Meta-Analysis and Systematic Review","volume":"195","author":"Lee","year":"2019","journal-title":"Strahlenther. Onkol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejrad.2007.01.037","article-title":"Brachytherapy and Percutaneous Stenting in the Treatment of Cholangiocarcinoma: A Prospective Randomised Study","volume":"62","author":"Kysela","year":"2007","journal-title":"Eur. J. Radiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2478\/raon-2023-0059","article-title":"Locoregional Therapy Combined with Systemic Therapy (LRT + ST) for Unresectable and Metastatic Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis","volume":"57","author":"Zhang","year":"2023","journal-title":"Radiol. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s00270-017-1827-6","article-title":"A Systematic Review and Meta-Analysis of Intraluminal Brachytherapy Versus Stent Alone in the Treatment of Malignant Obstructive Jaundice","volume":"41","author":"Xu","year":"2018","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1278-3218(01)00144-5","article-title":"Conformal therapy of locally advanced cholangiocarcinoma of the main bile ducts","volume":"6","author":"Bouras","year":"2002","journal-title":"Cancer Radiother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1586\/egh.12.20","article-title":"Management of Perihilar Cholangiocarcinoma in the Era of Multimodal Therapy","volume":"6","author":"Valero","year":"2012","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1200\/JCO.2014.60.2219","article-title":"SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma","volume":"33","author":"Guthrie","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.2147\/OTT.S131873","article-title":"Results of Adjuvant Radiation Therapy for Locoregional Perihilar Cholangiocarcinoma after Curative Intent Resection","volume":"10","author":"Leng","year":"2017","journal-title":"OncoTargets Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.gassur.2024.01.004","article-title":"Does Adjuvant Treatment Improve Survival in R1 Resected Perihilar Cholangiocarcinoma? The Risk of Overtreatment","volume":"28","author":"Panettieri","year":"2024","journal-title":"J. Gastrointest. Surg."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1245\/s10434-018-6388-7","article-title":"Adjuvant Therapy Is Associated with Improved Survival in Resected Perihilar Cholangiocarcinoma: A Propensity Matched Study","volume":"25","author":"Nassour","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1007\/s00432-021-03524-7","article-title":"Adjuvant Radiotherapy and Chemotherapy Offer a Recurrence and Survival Benefit in Patients with Resected Perihilar Cholangiocarcinoma","volume":"147","author":"Im","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2004-828896","article-title":"Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma","volume":"24","author":"Heimbach","year":"2004","journal-title":"Semin. Liver Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.sla.0000179678.13285.fa","article-title":"Liver Transplantation with Neoadjuvant Chemoradiation Is More Effective than Resection for Hilar Cholangiocarcinoma","volume":"242","author":"Rea","year":"2005","journal-title":"Ann. Surg."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2012.04.008","article-title":"Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers","volume":"143","author":"Kim","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1097\/TP.0000000000003114","article-title":"Neoadjuvant Chemoradiotherapy and Liver Transplantation for Unresectable Hilar Cholangiocarcinoma: The Irish Experience of the Mayo Protocol","volume":"104","author":"Zaborowski","year":"2020","journal-title":"Transplantation"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1055\/s-0034-1392044","article-title":"Endoscopically Inserted Nasobiliary Catheters for High Dose-Rate Brachytherapy as Part of Neoadjuvant Therapy for Perihilar Cholangiocarcinoma","volume":"47","author":"Mukewar","year":"2015","journal-title":"Endoscopy"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/jso.24836","article-title":"Adjuvant Therapy Is Associated with Improved Survival after Curative Resection for Hilar Cholangiocarcinoma: A Multi-Institution Analysis from the U.S. Extrahepatic Biliary Malignancy Consortium","volume":"117","author":"Krasnick","year":"2018","journal-title":"J. Surg. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/cncr.34625","article-title":"Outcomes of Adjuvant Radiation Therapy after Chemotherapy in Resected Extrahepatic Cholangiocarcinoma: A National Cancer Database Analysis","volume":"129","author":"Shridhar","year":"2023","journal-title":"Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"zrad025","DOI":"10.1093\/bjsopen\/zrad025","article-title":"Role of Neoadjuvant Chemoradiotherapy in Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma: Multicentre, Retrospective Cohort Study","volume":"7","author":"Hoogwater","year":"2023","journal-title":"BJS Open"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1245\/s10434-022-12863-9","article-title":"Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809)","volume":"30","author":"Gholami","year":"2023","journal-title":"Ann. Surg. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1245\/s10434-024-15117-y","article-title":"Adjuvant Chemoradiation in Resected Biliary Adenocarcinoma: Evaluation of SWOG S0809 with a Large National Database","volume":"31","author":"Dominguez","year":"2024","journal-title":"Ann. Surg. Oncol."},{"key":"ref_59","first-page":"737","article-title":"Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-Term Results of a Phase II Study","volume":"36","author":"Autorino","year":"2016","journal-title":"Anticancer Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1245\/s10434-024-15582-5","article-title":"Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease","volume":"31","author":"Buettner","year":"2024","journal-title":"Ann. Surg. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/MCG.0000000000000526","article-title":"Palliative Locoregional Treatment for Unresectable Nonmetastatic Klatskin Tumor: Percutaneous Transhepatic Biliary Drainage Combined with 3-Dimensional Conformal Radiotherapy","volume":"50","author":"Liu","year":"2016","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_62","first-page":"1951","article-title":"Impact of Intraoperative Radiotherapy (IORT) on Survival of Patients with Unresectable Hilar Cholangiocarcinoma","volume":"55","author":"Kaiser","year":"2008","journal-title":"Hepatogastroenterology"},{"key":"ref_63","first-page":"954","article-title":"Relief of Jaundice by External Beam Radiotherapy and Intraluminal Brachytherapy in Patients with Extrahepatic Cholangiocarcinoma: Results without Stenting","volume":"51","author":"Ishii","year":"2004","journal-title":"Hepatogastroenterology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00130404-200201000-00013","article-title":"High-Dose-Rate Remote Afterloading Intracavitary Brachytherapy for the Treatment of Extrahepatic Biliary Duct Carcinoma","volume":"8","author":"Lu","year":"2002","journal-title":"Cancer J."},{"key":"ref_65","first-page":"757","article-title":"Unresectable Hilar Cholangiocarcinoma: Multimodality Approach with Percutaneous Treatment Associated with Radiotherapy and Chemotherapy","volume":"20","author":"Golfieri","year":"2006","journal-title":"In Vivo"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1245\/s10434-014-4146-z","article-title":"Salvage Radiation Therapy for Isolated Local Recurrence of Extrahepatic Cholangiocarcinoma after Radical Surgery: A Retrospective Study","volume":"22","author":"Kim","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"6674","DOI":"10.3390\/curroncol29090524","article-title":"Surgical Treatment of Distal Cholangiocarcinoma","volume":"29","author":"Gorji","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.asjsur.2015.07.002","article-title":"Survival after Surgical Resection of Distal Cholangiocarcinoma: A Systematic Review and Meta-Analysis of Prognostic Factors","volume":"40","author":"Zhou","year":"2017","journal-title":"Asian J. Surg."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/cncr.33356","article-title":"Survival Benefit with Adjuvant Radiotherapy after Resection of Distal Cholangiocarcinoma: A Propensity-Matched National Cancer Database Analysis","volume":"127","author":"Kamarajah","year":"2021","journal-title":"Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/jso.27146","article-title":"Impact of Adjuvant Therapy on Outcomes after Curative-Intent Resection for Distal Cholangiocarcinoma","volume":"127","author":"Hou","year":"2023","journal-title":"J. Surg. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.ijrobp.2004.12.059","article-title":"Adjuvant External-Beam Radiotherapy with Concurrent Chemotherapy after Resection of Primary Gallbladder Carcinoma: A 23-Year Experience","volume":"62","author":"Czito","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ejso.2016.12.008","article-title":"A Retrospective Analysis of the Clinical Effects of Neoadjuvant Combination Therapy with Full-Dose Gemcitabine and Radiation Therapy in Patients with Biliary Tract Cancer","volume":"43","author":"Kobayashi","year":"2017","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/annonc\/mdp005","article-title":"Feasibility of Radiotherapy with Concomitant Gemcitabine and Oxaliplatin in Locally Advanced Pancreatic Cancer and Distal Cholangiocarcinoma: A Prospective Dose Finding Phase I\u2013II Study","volume":"20","author":"Laurent","year":"2009","journal-title":"Ann. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1080\/0284186X.2019.1590634","article-title":"Treatment and Survival of Resected and Unresected Distal Cholangiocarcinoma: A Nationwide Study","volume":"58","author":"Strijker","year":"2019","journal-title":"Acta Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased Survival in Pancreatic Cancer with Nab-Paclitaxel plus Gemcitabine","volume":"369","author":"Hoff","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1200\/JCO.2006.07.0201","article-title":"Randomized Phase III Study of Exatecan and Gemcitabine Compared with Gemcitabine Alone in Untreated Advanced Pancreatic Cancer","volume":"24","author":"Letourneau","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4251\/wjgo.v16.i1.13","article-title":"New Trends in Diagnosis and Management of Gallbladder Carcinoma","volume":"16","author":"Pavlidis","year":"2024","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3857\/roj.2021.00717","article-title":"Reviewing the Potential Role of Radiation Therapy in Gallbladder Cancer: An Update","volume":"40","author":"Kumar","year":"2022","journal-title":"Radiat. Oncol. J."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"41","DOI":"10.21037\/cco.2019.08.12","article-title":"Contemporary Perspectives on the Use of Radiation Therapy for Locally Advanced Gallbladder Cancer","volume":"8","author":"Verma","year":"2019","journal-title":"Chin. Clin. Oncol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13014-022-02091-6","article-title":"Postoperative Recurrent Patterns of Gallbladder Cancer: Possible Implications for Adjuvant Therapy","volume":"17","author":"Yuan","year":"2022","journal-title":"Radiat. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3857\/roj.2017.00388","article-title":"Patterns of Initial Failure after Resection for Gallbladder Cancer: Implications for Adjuvant Radiotherapy","volume":"35","author":"Kim","year":"2017","journal-title":"Radiat. Oncol. J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/jamaoncol.2024.1944","article-title":"Adjuvant Gemcitabine Plus Cisplatin and Chemoradiation in Patients with Gallbladder Cancer: A Randomized Clinical Trial","volume":"10","author":"Ostwal","year":"2024","journal-title":"JAMA Oncol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"djw202","DOI":"10.1093\/jnci\/djw202","article-title":"Adjuvant Therapy for Resected Gallbladder Cancer: Analysis of the National Cancer Data Base","volume":"109","author":"Mantripragada","year":"2017","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.amjsurg.2020.08.007","article-title":"Postsurgical Radiotherapy in Stage IIIB Gallbladder Cancer Patients with One to Three Lymph Nodes Metastases: A Propensity Score Matching Analysis","volume":"221","author":"Cai","year":"2021","journal-title":"Am. J. Surg."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/jso.20831","article-title":"Adjuvant Radiation Therapy Is Associated with Improved Survival for Gallbladder Carcinoma with Regional Metastatic Disease","volume":"96","author":"Mojica","year":"2007","journal-title":"J. Surg. Oncol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1245\/s10434-016-5262-8","article-title":"Impact of Chemotherapy and External-Beam Radiation Therapy on Outcomes among Patients with Resected Gallbladder Cancer: A Multi-Institutional Analysis","volume":"23","author":"Kim","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Kim, T.H., Woo, S.M., Lee, W.J., Oh, E.S., Youn, S.H., Moon, S.H., Kim, S.S., Han, S.S., Park, S.-J., and Kim, D.Y. (2019). Benefit of Adjuvant Chemoradiotherapy in Resected Gallbladder Carcinoma. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-48099-z"},{"key":"ref_88","first-page":"931","article-title":"Role of Adjuvant Chemoradiotherapy and Chemotherapy in Patients with Resected Gallbladder Carcinoma: A Multi-Institutional Analysis (KROG 19-04)","volume":"19","author":"Lee","year":"2021","journal-title":"Cancer Biol. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4103\/jcrt.jcrt_1161_21","article-title":"Chemotherapy or Chemotherapy Followed by Consolidation Chemoradiation in Postoperative (Simple Cholecystectomy) Gall Bladder Cancer with Residual Disease, Unsuitable for Revision Surgery? Risk Stratification and Outcomes","volume":"19","author":"Alam","year":"2023","journal-title":"J. Cancer Res. Ther."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0360-3016(01)01764-3","article-title":"Adjuvant External Beam Radiation Therapy with Concurrent Chemotherapy in the Management of Gallbladder Carcinoma","volume":"52","author":"Kresl","year":"2002","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s12072-022-10343-6","article-title":"Benefit of Adjuvant Radiotherapy for Gallbladder Cancer: A Comparability-Based Meta-Analysis","volume":"16","author":"Choi","year":"2022","journal-title":"Hepatol. Int."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1245\/s10434-017-6139-1","article-title":"Adjuvant Chemoradiotherapy Is Associated with Improved Survival for Patients with Resected Gallbladder Carcinoma: A Systematic Review and Meta-Analysis","volume":"25","author":"Kim","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13014-020-1459-x","article-title":"A Meta-Analysis of the Efficacy of Postoperative Adjuvant Radiotherapy versus No Radiotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma","volume":"15","author":"Ren","year":"2020","journal-title":"Radiat. Oncol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1200\/JCO.18.02178","article-title":"Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline","volume":"37","author":"Shroff","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1245\/s10434-016-5197-0","article-title":"Neoadjuvant Chemoradiation Followed by Surgery for Locally Advanced Gallbladder Cancers: A New Paradigm","volume":"23","author":"Engineer","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Agrawal, S., Mohan, L., Mourya, C., Neyaz, Z., and Saxena, R. (2016). Asian Pacific Journal of Cancer Prevention, Sanjay Gandhi Post Graduate Institute of Medical Sciences. Available online: https:\/\/journal.waocp.org\/?sid=Entrez:PubMed&id=pmid:27221908&key=2016.17.4.2137.","DOI":"10.7314\/APJCP.2016.17.4.2137"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4103\/ijc.IJC_822_19","article-title":"Predictors of Toxicity after Neoadjuvant Chemoradiotherapy for Locally Advanced Gall Bladder Cancer","volume":"59","author":"Loyal","year":"2022","journal-title":"Indian J. Cancer"},{"key":"ref_98","first-page":"51","article-title":"Neoadjuvant chemoradiotherapy in gallbladder cancer","volume":"132","author":"Losada","year":"2004","journal-title":"Rev. Med. Chil."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejso.2018.08.020","article-title":"The Role of Neoadjuvant Chemotherapy or Chemoradiotherapy for Advanced Gallbladder Cancer\u2014A Systematic Review","volume":"45","author":"Hakeem","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.surg.2013.06.001","article-title":"Impact of Adjuvant External Beam Radiotherapy on Survival in Surgically Resected Gallbladder Adenocarcinoma: A Propensity Score-Matched Surveillance, Epidemiology, and End Results Analysis","volume":"155","author":"Hyder","year":"2014","journal-title":"Surgery"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"S1100","DOI":"10.1245\/s10434-015-4685-y","article-title":"Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-Institutional Experience","volume":"22","author":"Wang","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1007\/s11605-015-2922-0","article-title":"Adjuvant Therapy for Gallbladder Cancer: An Analysis of the National Cancer Data Base","volume":"19","author":"Hoehn","year":"2015","journal-title":"J. Gastrointest. Surg."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/SLA.0000000000002385","article-title":"Surgical Management of Gallbladder Cancer: Simple Versus Extended Cholecystectomy and the Role of Adjuvant Therapy","volume":"266","author":"Kasumova","year":"2017","journal-title":"Ann. Surg."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijrobp.2017.09.029","article-title":"Concurrent Chemoradiotherapy in Curatively Resected Gallbladder Carcinoma: A Propensity Score\u2013Matched Analysis","volume":"100","author":"Gu","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3857\/roj.2020.00626","article-title":"Real World Clinical Outcomes of Adjuvant Sequential Chemoradiation in Patients with Gallbladder Carcinomas with Poor Performance Status","volume":"38","author":"Kapoor","year":"2020","journal-title":"Radiat. Oncol. J."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.4103\/jcrt.JCRT_550_19","article-title":"Influence of Adjuvant Therapy on Pattern of Failure and Survival in Curatively Resected Gallbladder Carcinoma","volume":"17","author":"Choudhary","year":"2021","journal-title":"J. Cancer Res. Ther."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1159\/000517113","article-title":"Adjuvant Therapy in Resected Nonmetastatic Stage II\u2013IV Gallbladder Cancer: A Generalized Propensity Score Analysis","volume":"44","author":"Wan","year":"2021","journal-title":"Oncol. Res. Treat."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Song, J., Kang, X., Di, Y., Ren, G., and Wang, Y. (2022). Associations between External Beam Radiotherapy and Overall Survival in Patients with Gallbladder Cancer: A Population-Based Study. Front. Public Health, 10.","DOI":"10.3389\/fpubh.2022.1012142"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ejso.2021.09.002","article-title":"Adjuvant Radiotherapy Improves Long-Term Survival after Resection for Gallbladder Cancer A Population-Based Cohort Study","volume":"48","author":"Kamarajah","year":"2022","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijrobp.2024.11.099","article-title":"A Randomized Study of Consolidation Chemoradiotherapy Versus Observation After First-Line Chemotherapy in Advanced Gallbladder Cancers: RACE-GB Study","volume":"122","author":"Agrawal","year":"2025","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/jcrt.JCRT_1568_20","article-title":"Radiotherapy for Locally Advanced Unresectable Gallbladder Cancer\u2014A Way Forward: Comparative Study of Chemotherapy versus Chemoradiotherapy","volume":"18","author":"Sinha","year":"2022","journal-title":"J. Cancer Res. Ther."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"59","DOI":"10.6004\/jnccn.2017.7067","article-title":"Chemoradiotherapy Versus Chemotherapy Alone for Unresected Nonmetastatic Gallbladder Cancer: National Practice Patterns and Outcomes","volume":"16","author":"Verma","year":"2018","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4103\/ijc.IJC_1145_20","article-title":"Consolidation Chemoradiation (cCTRT) Improves Survival in Responders to First-Line Chemotherapy (CT) in Locally Advanced Gallbladder Cancer (LA-GBC): A New Standard of Care?","volume":"59","author":"Alam","year":"2022","journal-title":"Indian J. Cancer"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/2278-0513.130214","article-title":"Best Supportive Care Compared with Chemotherapy and Radiotherapy for Unresectable Gallbladder Cancer: A Tertiary Care Institute Experience","volume":"3","author":"Singh","year":"2014","journal-title":"Clin. Cancer Investig. J."},{"key":"ref_115","first-page":"581","article-title":"Is External Palliative Radiotherapy for Gallbladder Carcinoma Effective?","volume":"24","author":"Eleftheriadis","year":"2001","journal-title":"Onkologie"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/jso.21374","article-title":"Cancers of the Ampulla of Vater: Demographics, Morphology, and Survival Based on 5,625 Cases from the SEER Program","volume":"100","author":"Schwartz","year":"2009","journal-title":"J. Surg. Oncol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"753","DOI":"10.6004\/jnccn.2023.0034","article-title":"Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Chiorean","year":"2023","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_118","unstructured":"National Comprehensive Cancer Network (2025, June 06). NCCN Guidelines Version Ampullary Adenocarcinoma. Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/ampullary.pdf."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00000658-199912000-00006","article-title":"Adjuvant Radiotherapy and 5-Fluorouracil After Curative Resection of Cancer of the Pancreas and Periampullary Region","volume":"230","author":"Klinkenbijl","year":"1999","journal-title":"Ann. Surg."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archsurg.136.1.65","article-title":"Adjuvant Chemoradiotherapy for \u201cUnfavorable\u201d Carcinoma of the Ampulla of Vater: Preliminary Report","volume":"136","author":"Mehta","year":"2001","journal-title":"Arch. Surg."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0360-3016(00)00537-X","article-title":"Outcome of Pancreaticoduodenectomy and Impact of Adjuvant Therapy for Ampullary Carcinomas","volume":"47","author":"Lee","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ijrobp.2006.04.018","article-title":"Adjuvant Therapy for Ampullary Carcinomas: The Mayo Clinic Experience","volume":"66","author":"Bhatia","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1748-717X-6-126","article-title":"Evaluation of Adjuvant Chemoradiation Therapy for Ampullary Adenocarcinoma: The Johns Hopkins Hospital-Mayo Clinic Collaborative Study","volume":"6","author":"Narang","year":"2011","journal-title":"Radiat. Oncol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1007\/s12094-018-1849-9","article-title":"Adjuvant Radiotherapy Following Pancreaticoduodenectomy for Ampullary Adenocarcinoma Improves Survival in Node-Positive Patients: A Propensity Score Analysis","volume":"20","author":"Kamarajah","year":"2018","journal-title":"Clin. Transl. Oncol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejso.2004.08.013","article-title":"Adjuvant Chemo-Radiotherapy in Ampullary Cancers","volume":"31","author":"Sikora","year":"2005","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ijrobp.2007.07.2327","article-title":"Role of Adjuvant Chemoradiation Therapy in Adenocarcinomas of the Ampulla of Vater","volume":"70","author":"Krishnan","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.radonc.2009.05.006","article-title":"Adjuvant Chemoradiation versus Surgery Alone for Adenocarcinoma of the Ampulla of Vater","volume":"92","author":"Zhou","year":"2009","journal-title":"Radiother. Oncol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s11605-014-2629-7","article-title":"Defining the Role of Adjuvant External Beam Radiotherapy on Resected Adenocarcinoma of the Ampulla of Vater","volume":"18","author":"Miura","year":"2014","journal-title":"J. Gastrointest. Surg."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.hpb.2019.03.369","article-title":"The Role of Radiotherapy in Patients with Resected Ampullary Carcinoma: Findings Based on the SEER Database","volume":"21","author":"Zhao","year":"2019","journal-title":"HPB"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"560","DOI":"10.14740\/jocmr4267","article-title":"The Clinical Benefit of Adjuvant Therapy in Long-Term Survival of Early-Stage Ampullary Carcinoma: A Single Institutional Experience","volume":"12","author":"Manne","year":"2020","journal-title":"J. Clin. Med. Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.hbpd.2024.07.002","article-title":"Survival Benefit of Adjuvant Treatment for Ampullary Cancer with Lymph Nodal Involvement: A Systematic Review and Meta-Analysis","volume":"23","author":"Kim","year":"2024","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1245\/s10434-011-2117-1","article-title":"Carcinoma of the Ampulla of Vater: Patterns of Failure Following Resection and Benefit of Chemoradiotherapy","volume":"19","author":"Palta","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1245\/s10434-017-5777-7","article-title":"Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater","volume":"24","author":"Cloyd","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Facer, B.D., Cloyd, J.M., Manne, A., Pitter, K.L., Diaz, D.A., Bazan, J.G., and Miller, E.D. (2023). Treatment Patterns and Outcomes for Patients with Ampullary Carcinoma Who Do Not Undergo Surgery. Cancers, 15.","DOI":"10.3390\/cancers15143727"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/COC.0000000000000075","article-title":"Prognostic Significance of Nodal Ratio in Patients Undergoing Adjuvant Chemoradiotherapy After Curative Resection for Ampullary Cancer","volume":"39","author":"Kim","year":"2016","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"519","DOI":"10.4103\/ijc.IJC_358_17","article-title":"Compliance and Outcomes of Concurrent Chemo-Radiation in Patients with Peri-Ampullary Cancer Undergoing Curative Resections","volume":"54","author":"Pathy","year":"2017","journal-title":"Indian J. Cancer"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1200\/JCO.2025.43.16_suppl.4007","article-title":"A Phase III Randomized Clinical Trial Evaluating Perioperative Therapy (Neoadjuvant Chemotherapy versus Chemoradiotherapy) in Locally Advanced Gallbladder Cancers (POLCAGB)","volume":"43","author":"Engineer","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Koo, T., Cheong, K.-H., Kim, K., Park, H.J., Park, Y., Koh, H.K., Kim, B.H., Kim, E., Kim, K.S., and Choi, J.H. (2022). Variation in clinical target volume delineation in postoperative radiotherapy for biliary tract cancer. PLoS ONE., 17.","DOI":"10.1371\/journal.pone.0273395"},{"key":"ref_139","first-page":"1784","article-title":"An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer","volume":"17","author":"Bisello","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.prro.2013.06.004","article-title":"Upper abdominal normal organ contouring guidelines and atlas: A Radiation Therapy Oncology Group consensus","volume":"4","author":"Jabbour","year":"2014","journal-title":"Pract. Radiat. Oncol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ijrobp.2012.01.022","article-title":"Radiation Therapy Oncology Group Consensus Panel Guidelines for the Delineation of the Clinical Target Volume in the Postoperative Treatment of Pancreatic Head Cancer","volume":"83","author":"Goodman","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/10\/545\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:43:14Z","timestamp":1759156994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/10\/545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,28]]},"references-count":141,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["curroncol32100545"],"URL":"https:\/\/doi.org\/10.3390\/curroncol32100545","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,28]]}}}